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Characterization of the Human Visceral
Adipose Tissue Secretome*□S
Gloria Alvarez-Llamas‡, Ewa Szalowska‡, Marcel P. de Vries‡, Desiree Weening‡,
Karloes Landman‡, Annemieke Hoek§, Bruce H. R. Wolffenbuttel¶, Han Roelofsen‡,
and Roel J. Vonk‡
Adipose tissue is an endocrine organ involved in storage
and release of energy but also in regulation of energy
metabolism in other organs via secretion of peptide and
protein hormones (adipokines). Especially visceral adi-
pose tissue has been implicated in the development of
metabolic syndrome and type 2 diabetes. Factors se-
creted by the stromal-vascular fraction contribute to the
secretome and modulate adipokine secretion by adipo-
cytes. Therefore, we aimed at the characterization of the
adipose tissue secretome rather than the adipocyte cell
secretome. The presence of serum proteins and intracel-
lular proteins from damaged cells, released during cul-
ture, may dramatically influence the dynamic range of the
sample and thereby identification of secreted proteins.
Part of the study was therefore dedicated to the influence
of the culture setup on the quality of the final sample.
Visceral adipose tissue was cultured in five experimental
setups, and the quality of resulting samples was evalu-
ated in terms of protein concentration and protein com-
position. The best setup involved one wash after the 1st h
in culture followed by two or three additional washes
within an 8-h period, starting after overnight culture.
Thereafter tissue was maintained in culture for an addi-
tional 48–114 h to obtain the final sample. For the secre-
tome experiment, explants were cultured in media con-
taining L-[13C6,
15N2]lysine to validate the origin of the
identified proteins (adipose tissue- or serum-derived). In
total, 259 proteins were identified with >99% confidence.
108 proteins contained a secretion signal peptide of which
70 incorporated the label and were considered secreted
by adipose tissue. These proteins were classified into five
categories according to function. This is the first study on
the (human) adipose tissue secretome. The results of this
study contribute to a better understanding of the role of
adipose tissue in whole body energy metabolism and re-
lated diseases. Molecular & Cellular Proteomics 6:
589–600, 2007.
Adipose tissue is a key organ for the regulation of energy
metabolism. Besides its function as an energy storage depot
in the form of triglycerides, adipose tissue secretes a variety
of peptide and protein hormones (adipokines) involved in the
regulation of energy metabolism such as leptin, adiponectin,
visfatin, retinol-binding protein-4, adipsin, tumor necrosis fac-
tor  (TNF-)1 and interleukin 6 (1–3). Dysregulation of the
production of adipokines and free fatty acids contributes to
the pathogenesis of diseases associated with energy metab-
olism such as insulin resistance, metabolic syndrome, and
type 2 diabetes. Especially visceral adipose tissue has been
implicated in the development of these diseases (2–4). There-
fore, more insight into the visceral adipose tissue secretome
will contribute to a better understanding of its role in energy
metabolism and related diseases and may lead to the discov-
ery of unknown peptides/proteins involved in regulation of
energy metabolism and new targets for therapy. Besides adi-
pocytes, adipose tissue contains endothelial cells, macro-
phages, and fibroblasts (stromal fraction) that may modulate
the overall peptide and protein secretion pattern of the tissue
via cross-talk between the different cell types. For example,
factors secreted by macrophages have been shown to induce
changes in the secretion of adipokines, free fatty acids, and
glucose uptake by 3T3-L1 adipocytes (5). These interactions
between cells from the stromal fraction and adipocytes are
necessary for physiological functions of adipose tissue, and
deregulation of this cross-talk is regarded as an important
mechanism leading to insulin resistance and type 2 diabetes
(6–9). Therefore, the tissue secretome provides more relevant
information for the in vivo situation than the adipocyte cell
secretome. To date, no studies have been published on the
adipose tissue secretome. Several studies investigated the
human (10), mouse (11–14), and rat (15) adipose tissue pro-
teome, mostly using a two-dimensional gel electrophoresis
approach. Celis et al. (16) analyzed the human mammary
adipose tissue proteome. The secretome from adipocyte cells
has been investigated by Kratchmarova et al. (17) and Wang
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et al. (18). They studied changes in protein secretion during
differentiation of the 3T3-L1 mouse preadipocyte cell line to
adipocytes. In another study in isolated rat adipocytes, Chen
et al. (19) identified 84 secreted proteins using 2D LC-MS/MS.
The major challenge for characterization of the adipose
tissue secretome is the quality of the secretome sample. The
presence of serum proteins inside the tissue pieces that
slowly diffuse into the culture medium and the presence of
intracellular proteins that are released from damaged cells
due to the cutting of the tissue, necessary for culture, can
dramatically influence the dynamic range of the sample and
thereby the detection of the secreted proteins. Also the rele-
vance of the identified proteins can be unclear if the source of
the proteins (secreted, serum, or intracellular) is not clear due
to a high level of contaminant proteins. This has been a
problem in previous studies with tissue explants where e.g.
adiponectin, secreted by the tissue, could not be reliably
measured due to diffusion of serum adiponectin, as a second
source of adiponectin, from the tissue into the culture medium
(20). In addition, the duration of the culture influences the level
of secreted proteins that accumulate in the medium but may
also affect the function and breakdown of cells in the tissue.
In view of secretome complexity and considering that adipo-
kines are expected in low concentrations (ng/ml), the quality
of the sample obtained from tissue culture is crucial to obtain
high quality, relevant secretome data. Specific removal of high
abundance serum proteins in biological samples has been
described previously (21) but does not resolve the problem of
contamination derived from intracellular proteins. Further-
more low abundance proteins that bind to the high abun-
dance proteins may also be removed at the same time. There-
fore, we did not consider this option but carefully evaluated
the influence of the culture setup on the quality of the sample
for secretome analysis. For this purpose, the influence of
several culture setups that varied in the number of washes
and the distribution of washes in time was investigated. Pro-
tein concentration, dynamic range, and composition of the
resulting samples were then evaluated. From these experi-
ments the best culture setup was chosen for further secre-
tome characterization. Proteins were then identified by LC-
MS/MS after SDS-PAGE fractionation. The resulting list of
secreted proteins was validated by culturing adipose tissue in
the presence of stable isotope-labeled L-lysine. Proteins that
contain a signal peptide sequence and incorporate the label
are derived from adipose tissue and not from an external
source such as serum.
EXPERIMENTAL PROCEDURES
Adipose Tissue Culture—Human visceral adipose tissue explants
were obtained from five women (age, 25–64 years; body mass index,
19–31) undergoing surgery for non-carcinogenic gynecologic disor-
ders. For each culture setup (see Fig. 1), adipose tissue from one
subject was used. The study had the approval of the local ethical
committee.
The adipose tissue culture protocol is based on Fried and
Moustaid-Moussa (22). Briefly adipose tissue explants were trans-
ported from the operating room to the laboratory in transport buffer
(PBS, 5.5 mM glucose, 50 g/ml gentamicin) at room temperature.
The following procedures were carried out under a laminar flow hood
using sterile equipment. Immediately upon arrival, the tissue was
transferred to a Petri dish containing 20 ml of PBS and was finely
minced in 20–80-mg pieces using scissors. The tissue pieces were
extensively washed with 400 ml of PBS over a filter containing sterile
cotton bandage fabric. Thereafter the tissue pieces were transferred
to a 75-cm2 culture flask containing 200 ml of PBS and were gently
shaken for a short period. Next the contents of the flask were poured
over the filter, and the tissue pieces were washed with 300 ml of warm
PBS (37 °C). The tissue pieces were transferred to a tube containing
50 ml of PBS and centrifuged for 1 min at 277  g at room temper-
ature to remove red blood cells and debris. The tissue was then
removed from the tube, and the weight was determined. 1 g of tissue
was then placed in a Petri dish with 10 ml of M199 (Invitrogen) culture
medium supplemented with 50 g/ml gentamicin. Adipose tissue
pieces were cultured at 37 °C and 5% CO2 following the different
culture setups (Fig. 1). The final secretome sample and the media
collected after every washing step in culture (Fig. 1) were stored at
80 °C.
Sample Pretreatment—9–10 ml of adipose tissue culture medium
was concentrated 25–30-fold by ultrafiltration (Centriplus, 3-kDa cut-
off, Millipore). The concentrated sample was used for total protein
concentration measurement (Bradford assay, Bio-Rad), SELDI-TOF
MS profiling, and protein identification by LC-MS/MS.
SELDI-TOF MS Protein Profiling—Spots of a CM10 (weak cation
exchanger) ProteinChip array (Ciphergen Biosystems, Fremont, CA),
inserted into a bioprocessor, were preincubated twice with 200 l of
binding buffer (100 mM ammonium acetate, 0.05% Triton, pH 4.0) for
5 min at room temperature with vigorous shaking. The buffer was then
removed, and 4–12 l of concentrated sample (depending on protein
concentration) were applied on every spot. Binding buffer was added
to a total volume of 100 l/well (g of protein was adjusted so that the
same protein amount per spot was applied). After incubation for 30
min, the sample was removed, and the spots were washed three
times with 200 l of binding buffer for 5 min followed by a wash with
200 l of ultrapure water. The water was removed, and the chip was
allowed to air dry before applying 2  0.5 l of 5 mg -cyano-4-
hydroxycinnamic acid diethylamine salt dissolved in 1 ml of 50%
ACN, 0.5% TFA. Mass analysis was performed in a ProteinChip
reader (model PBS II, Ciphergen Biosystems) according to an auto-
mated data collection protocol. Calibration was performed with the
All-in-One peptide mixture (Ciphergen Biosystems), and spectra were
obtained in the mass range 3.5–100 kDa at several laser intensities
(175–225).
Label Experiment—An adipose tissue explant from a patient un-
dergoing surgery for uterus myomatosis (47 years old; body mass
index, 22.9) was collected, cut, washed, and divided into two Petri
dishes as described above. In this experiment, tissue was cultured
from the start in lysine-free M199 medium (Invitrogen) to deplete
lysine from other sources (serum). The medium was renewed after 1,
21.5, 25.5, and 29.5 h. In the last wash (time point, 29.5 h), one
dish received normal M199 medium containing 70 mg/liter
L-[12C6,
14N2]lysine and 60 nM insulin. The other dish received M199
lysine-free medium containing 70 mg/liter labeled lysine (L-lysine:
2HCl; U-13C6, 98%; U-
15N2, 98%; Cambridge Isotope Laboratories,
Inc., Andover, MA) and 60 nM insulin. Tissue was maintained in culture
for an additional 72 h. Thereafter media were collected and stored at
80 °C until analysis. Normal and labeled media were then mixed in
1:2 ratio and were concentrated by ultrafiltration before SDS-PAGE
fractionation.
Protein Identification by LC-MS/MS—Proteins present in the con-
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centrated adipose tissue medium sample were fractionated by SDS-
PAGE on a 4–12% bis-Tris gel with a MOPS buffer system according
to the manufacturer’s protocol (NuPAGE-Novex, Invitrogen). Protein
separation occurred for 50 min at 200 V, and visualization of bands
was performed overnight by Coomassie Brilliant Blue G-250-based
staining (PageBlue staining solution, Fermentas). The whole lane was
excised into 28 bands, which were processed for tryptic digestion.
Each band was cut into small pieces and stored at 20 °C until
analysis. Then the pieces were washed in ultrapure water and dehy-
drated in ACN. In-gel reduction with dithiothreitol (for 1 h at 60 °C) and
carbamidomethylation with iodoacetamide (for 45 min at room tem-
perature in the dark) were performed. Gel pieces were subsequently
washed with ultrapure water, 50% ACN, and pure ACN. Next 0.1 g
of trypsin in 50 mM ammonium bicarbonate was added, and gel
pieces were allowed to rehydrate on ice for 20 min. Digestion was
carried out overnight at 37 °C.
Separation of the resulting tryptic peptide mixtures was performed
by nanoscale reversed-phase LC-MS/MS. The Agilent 1100 nano-
flow/capillary LC system (Agilent, Palo Alto, CA) was equipped with a
trapping column (5  0.3 mm C18 reversed-phase) (Dionex/LC Pack-
ings, Amsterdam, The Netherlands) and a nanocolumn (150  0.075
mm, C18 PepMap) (Dionex/LC Packings). Peptides mixtures were
injected into the trapping column at a flow rate of 10 l/min (3% ACN,
0.1% FA). After 10 min the trapping column was switched into the
nanoflow system, and the trapped peptides were separated using the
nanocolumn at a flow rate of 0.3 l/min in a linear gradient elution
from 95% A (3% ACN, 0.1% FA) to 50% B (97% ACN, 0.1% FA) in 50
min followed by an increase up to 80% B in 3 min. The eluting
peptides were on-line electrosprayed into the QStar XL hybrid ESI
quadrupole time-of-flight tandem mass spectrometer, ESI-qQ-TOF-
MS/MS (Applied Biosystems, Framingham, MA; MDS Sciex, Con-
cord, Ontario, Canada), provided with a nanospray source equipped
with a New Objective ESI needle (10-m tip diameter). Typical values
for needle voltage were 2 kV in positive ion mode. Analyst QS 1.1
software (Applied Biosystems) was used for data acquisition in the
positive ion mode typically with a selected mass range of 300–1200
m/z. Peptides with 2 to 4 charge states were selected for tandem
mass spectrometry, and the time of summation of MS/MS events was
set to be 2 s. The three most abundant charged peptides above a 40
count threshold were selected for MS/MS and dynamically excluded
for 40 s with 100-ppm mass tolerance.
ProID 1.1 software (Applied Biosystems) (23) was used to identify
proteins from the mass spectrometric datasets according to the
Swiss-Prot database (May 2005, 181,000 entries). Mass tolerance
was set to 0.15 Da (MS) and 0.1 Da (MS/MS), and carboxamidom-
ethylation and methionine oxidation were chosen as modifications for
database search.
Classification of identified proteins in terms of secretion pathways
was performed according to SecretomeP 2.0 Server (24). Those pro-
teins with a signal peptide predicted by SignalP were considered as
secreted proteins via a classical pathway (endoplasmic reticulum/Golgi-
dependent pathway). If no signal peptide was predicted but the Neural
Network score exceeded a value of 0.6, proteins were classified as
secreted via the non-classical pathway. Transmembrane helices and
location were predicted according to TMHMM Server (25). MS spectra
of identified peptides that showed a lysine in the C terminus were
searched for shifts of 8, 4, or 2.666m/z (singly, doubly, or triply charged
ions, respectively). If a peptide incorporated the label, the derived pro-
tein was considered to be synthesized by adipose tissue.
RESULTS
Evaluation of Culture Setup and Sample Quality—The
standard adipose tissue culture protocol involves cutting of
the tissue explants into small pieces followed by several
washing steps to remove serum and intracellular proteins
before culturing as described under “Experimental Proce-
dures.” Because of the cutting, damaged cells will slowly lose
their contents into the medium. Furthermore serum proteins
still present in the tissue pieces will diffuse out during culture.
Therefore, additional washing steps during culture were nec-
essary to obtain a sample for secretome analyses containing
mainly adipose tissue-derived secreted proteins. In prelim-
inary studies we evaluated the protein composition of the
adipose tissue medium, cultured for 48 h with one washing
step after the 2nd h of culture (Fig. 1, setup A). After in-
solution digestion of the final sample and LC-MS/MS anal-
ysis, 42 proteins were identified with 95% confidence
(results not shown). According to the Human Protein Refer-
ence Database (HPRD) (26) none of them could be directly
related to a protein secreted by adipose tissue. Typical serum
proteins (albumin, hemoglobin, and transferrin) and intracel-
lular proteins (actin, histones, and perilipin) dominated the
secretome composition.
FIG. 1. Distribution of washing steps in time for the different culture setups (A–E) assayed. An inset is included for visualizing the
distribution of washes at the beginning of the culture period (first 6 h).
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To reduce the concentration of these high abundance con-
taminating proteins, five different culture setups were evalu-
ated including the setup mentioned above as control (see Fig.
1). The number of washes (replacement with fresh media)
during tissue culture, as well as their distribution in time, were
varied to evaluate effects on the quality of the final sample for
secretome analyses. Processing of the visceral adipose tissue
explants, obtained from the five patients (A–E), was the same
(described under “Experimental Procedures”). During culture,
washing steps were performed by replacing media (10 ml)
with 10 ml of fresh media according to the different schemes
(A–E) depicted in Fig. 1. The media of the washing steps and
the final secretome samples were collected for further analy-
ses. Protein concentration was measured to evaluate the
effectiveness of the different culture setups on removing (high
abundance) serum and intracellular proteins. According to
Fig. 2, protein concentrations in the final media samples were
the lowest in setups D and E. This suggests that setups D and
E were better in removing high abundance proteins when
compared with setups A and B, whereas setup C gave an
intermediate result.
The protein composition of the final samples obtained from
each culture setup was investigated by SDS-PAGE (Fig. 3)
and SELDI-TOF MS (Fig. 4). When comparing the lanes with
samples of the indicated culture setups (Fig. 3), it was clear
that samples from setups A and B showed less uniformity in
intensity of bands than those of setups C, D, and E.
We also used SELDI profiling to monitor changes in the
dynamic range of the samples that are expected to occur if
high abundance contaminating proteins are removed more
efficiently. High abundance proteins are likely to suppress
ionization of low abundance proteins (27). As a consequence,
with a certain laser energy, a lower total number of peaks can
be expected in a sample with large concentration differences
compared with a sample with small differences in concentra-
tion of individual proteins. We made use of this phenomenon
to evaluate the dynamic range of the final samples resulting
from the different culture setups (A–E). For this, spectra were
obtained for every sample at four different laser intensities in
the mass range from 3.5 to 17.5 kDa. Fig. 4.1 shows an
example of spectra obtained for the different setups with the
lowest laser intensity (175). From these spectra it can already
be deduced that samples of setups D and E showed consid-
erably more peaks than samples from the other three setups
at this laser intensity. Total peak number (signal/noise ratio
5) was also calculated from all spectra and plotted against
laser intensity (Fig. 4.2). At laser intensity 190 still no maxi-
mum was reached in the number of detected peaks for setups
A, B, and C, whereas the number of peaks that could be
detected with setups D and E plateaued at laser intensities
180 and 185, respectively. This indicates that the dynamic
range of samples D and E is lower than that of the other
samples. We also monitored peak intensities of the  and 
chain of hemoglobin (predicted to be appearing at 15.1 and
15.9 kDa, respectively) and albumin (66 kDa) in the SELDI
spectra that clearly showed a reduction in peak intensity
(abundance) in spectra from samples D and E compared with
A, B, and C (Fig. 4.3).
Combining results of these analyses, we conclude that one
or two washing steps as used in setups A and B before
isolation of the final medium sample are clearly not sufficient.
FIG. 2. Total protein concentration
measured in media collected from ev-
ery washing step and in the final se-
cretome sample. On the x axis, consec-
utive time points are displayed per
experiment, and every time point repre-
sents the culture time since the previous
wash (periods of accumulation). The
black bars represent the initial protein
concentrations, and the gray bars refer
to the final protein concentrations for ev-
ery setup (A–E). Fig. 1 indicates the time
points when the samples were collected.
FIG. 3. SDS-PAGE (12% bis-Tris gel) of final secretome samples
obtained from the different culture setups as indicated in Fig. 1
(m, marker; A–E, final secretome samples).
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FIG. 4. 4.1, SELDI-TOF MS profiles (CM10 weak cation exchange chip) in the 3.5–17-kDa mass range at the lowest laser intensity (175). 4.2,
graph of total peak number plotted against laser intensity by SELDI-TOF MS as an indication of the dynamic range of the final secretome
samples. 4.3, SELDI-TOF MS spectra zoomed in at the mass range of hemoglobin and albumin (laser intensities, 185 and 225, respectively)
for the five setups (A–E).
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Secreted proteins (classical pathway; signal predicted by SignalP) that incorporated the label
The proteins were identified after SDS-PAGE fractionation and tryptic digest analysis by LC-MS/MS (99% confidence). ECM, extracellular
membrane; EGF, epidermal growth factor.
Accession no. Protein name
Signaling/regulatory function
gi14916999 78-kDa glucose-regulated protein (GRP 78) (immunoglobulin heavy chain-binding protein)
gi20137531 Adipocyte-derived leucine aminopeptidase (A-LAP) (ARTS-1) (aminopeptidase PILS)
gi2493789 Adiponectina,b,c
gi117501 Calreticulin (CRP55) (calregulin)a
gi1171064 Cell surface glycoprotein MUC18 (melanoma-associated antigen MUC18)d
gi20177861 Complement C1q tumor necrosis factor-related protein 5
gi23396772 Ectonucleotide pyrophosphatase/phosphodiesterase 2 (E-NPP 2)
gi17865698 Endoplasmin (94-kDa glucose-regulated protein) (GRP94)
gi23396609 Insulin-like growth factor-binding protein 7 (IGFBP-7) (IBP-7) (IGF-binding protein 7)a
gi117558 Macrophage colony-stimulating factor-1 (CSF-1) (MCSF) (M-CSF)d
gi9297107 Neuropilin-1 (vascular endothelial cell growth factor 165 receptor)d
gi118090 Peptidyl-prolyl cis-trans isomerase B (PPIase) (rotamase) (cyclophilin B)
gi46576887 Periostin (PN) (osteoblast-specific factor 2) (OSF-2)
gi3024715 Peroxiredoxin 4 (Prx-IV) (thioredoxin peroxidase AO372)
gi20178323 Pigment epithelium-derived factor (PEDF) (EPC-1)a,c
gi124096 Plasma protease C1 inhibitor (C1 Inh)a
gi62298174 Plasma retinol-binding protein (PRBP) (RBP)a
gi129576 PAI-1 (endothelial plasminogen activator inhibitor)a
gi401413 von Willebrand factor precursor (vWF)
ECM
gi24212664 Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (perlecan)
gi115269 Collagen  1(I) chainc
gi115306 Collagen  1(III) chainb,c
gi13878903 Collagen  1(VI) chainb,c
gi62901508 Collagen  1(XIV) chain (undulin)
gi728996 Collagen  1(XV) chain
gi45644997 Collagen  1(XVIII) chain
gi8039779 Collagen  2(I) chainc
gi115349 Collagen  2(IV) chaina,c
gi27808647 Collagen  2(VI) chainb,c
gi5921193 Collagen  3(VI) chainb
gi62510689 EGF-containing fibulin-like extracellular matrix protein 1 (fibulin-3)
gi2506872 Fibronectin (FN) (cold-insoluble globulin)
gi47115668 Galectin-3-binding protein (lectin galactoside-binding soluble 3-binding protein)
gi121116 Gelsolin (actin-depolymerizing factor) (ADF) (brevin)a,b,c
gi20141592 Laminin -4 chain
gi126366 Laminin -1 chain (laminin B1 chain)a
gi126369 Laminin -1 chain (laminin B2 chain)a
gi62298084 Matrilin-2
gi2506403 Microfibril-associated glycoprotein 4
gi128199 Nidogen (entactin) a,b
gi52783472 Spondin-1 (F-spondin) (vascular smooth muscle cell growth-promoting factor)
gi3915888 Tenascin (TN) (hexabrachion) (cytotactin) (neuronectin) (GMEM)
gi135717 Thrombospondin-1a
gi549136 Thrombospondin-2
gi2498193 Transforming growth factor--induced protein IG-H3 (IG-H3)
gi2506816 Versican core protein (large fibroblast proteoglycan)
Immune function
gi115205 Complement C1s subcomponent (C1 esterase)a
gi38257345 Complement C2 (C3/C5 convertase)a
gi116594 Complement C3b,c
gi20141171 Complement C4a
gi61252057 Complement component C7
gi584908 Complement factor B (C3/C5 convertase) (properdin factor B)a
gi3915626 Complement factor D (C3 convertase activator) (properdin factor D) (adipsin)a,b,c
gi48428995 Lysozyme C (1,4--N-acetylmuramidase C)
Human Visceral Adipose Tissue Secretome
594 Molecular & Cellular Proteomics 6.4












Setups D and E contained three or four washing steps, re-
spectively, distributed over a period of 24 h before the final
sample was obtained. This clearly gave better results also
when compared with setup C. Here six washing steps were
applied but all in the beginning of the tissue culture period.
Based on these analyses we conclude that culture protocols
D and E performed best.
Secretome Characterization—After the optimal culture
setup was established, this protocol was used for character-
ization of the secretome. To determine whether identified
proteins are secreted by adipose tissue or are derived from
serum that may still be present as a contaminant of the
sample, a labeling experiment was carried out. In this quali-
tative approach, an adipose tissue explant was divided into
two dishes. After the washing steps were performed in lysine-
free media (see “Experimental Procedures”), the tissue was
cultured for an additional 72 h. One dish contained medium
supplemented with L-[13C6,
15N2]lysine, and the other dish
contained normal medium containing L-[12C6,
14N2]lysine. To
facilitate detection of label incorporation by mass spectrom-
etry, media from both dishes were mixed in a 1:2 ratio in favor
of the stable isotope label. After concentration, the sample
was fractionated by SDS-PAGE. The lane was excised in 28
bands for tryptic digestion, and digests were analyzed by
LC-MS/MS for protein identification as described under “Ex-
perimental Procedures.” The complete list of identified pro-
teins and peptide sequences obtained from the MS/MS data
can be found in the Supplemental Table C. Peptide confi-
dences 5 are shown for each identified protein. Confidence
scores generated by the ProID software are explained in a
study by Tang et al. (23). By this approach, a total of 297
proteins could be identified with 95% confidence. Within
this group, 259 proteins were identified with 99% confi-
dence. Proteins identified with the highest confidence score
(99%) were analyzed for the presence of a signal peptide
using the SecretomeP 2.0 Server to determine whether they
were secreted. This analyses revealed that 108 of 259 pro-
teins were secreted following a classical pathway (endoplas-
mic reticulum/Golgi-dependent pathway) (see Tables I and II).
For all these proteins a signal peptide was predicted by Sig-
nalP. Some of them (marked with Footnote d in Tables I and
II) contained transmembrane helices located more than 40
amino acids away from the N terminus according to the
TMHMM Server. This implies that they were anchored to the
membrane. However, because a signal peptide was predicted
we considered them as secreted. The possibility exists that
they were released from the cell via cleavage of the extracel-
lular part of the protein. Proteins identified with 99% confi-
dence that contained a signal peptide were classified accord-
ing to whether or not they incorporated the label (Tables I and
II). Of 108 proteins containing a signal peptide, label incorpo-
ration could be confirmed for 70 of them (see Table I). These
proteins were considered genuine adipose tissue-secreted
proteins. For this, the MS spectra of the corresponding pep-
tides were manually checked for mass shifts due to label
incorporation as described under “Experimental Procedures.”
Some proteins were only identified by peptides ending on an
arginine at the C terminus (no lysine present). This leaves
open the possibility that they are derived from adipose tissue
although the label incorporation could not be detected (see
first group of non-labeled proteins in Table II).
As an example, Fig. 5 shows two MS spectra obtained for
TABLE I–continued
Accession no. Protein name
Involved in degradation
gi116856 72-kDa type IV collagenase (matrix metalloproteinase-2) (MMP-2)a,b,c
gi112911 2-Macroglobulin (2-M)
gi115711 Cathepsin B (cathepsin B1) (APP secretase)a
gi115717 Cathepsin Da
gi115741 Cathepsin L (major excreted protein) (MEP)
gi544413 Chitinase-3-like protein 1 (cartilage glycoprotein-39)
gi116852 Interstitial collagenase (matrix metalloproteinase-1) (MMP-1) (fibroblast collagenase)
gi116863 Matrix metalloproteinase-9 (MMP-9) (92-kDa type IV collagenase) (92-kDa gelatinase)a
gi135850 Metalloproteinase inhibitor 1 (TIMP-1) (erythroid potentiating activity) (EPA)a
gi6919941 Procollagen C-proteinase enhancer protein (PCPE)c
Other functions
gi119576 Liver carboxylesterase 1 (acyl-coenzyme A:cholesterol acyltransferase)
gi585223 Plasma glutathione peroxidase (GSHPx-P)
gi61221730 Protein C19orf10 (stromal cell-derived growth factor SF20) (interleukin-25)c
gi2507461 Protein-disulfide isomerase A3 (disulfide isomerase ER-60) (ERp60)
gi2507460 Protein-disulfide isomerase (PDI) (prolyl 4-hydroxylase  subunit)
gi136191 Serotransferrin (transferrin) (siderophilin) (-1-metal-binding globulin) a
a Secreted proteins also identified in Ref. 19.
b Secreted proteins also identified in Ref. 17.
c Secreted proteins also identified in Ref. 18.
d Signal peptide predicted by SignalP (24) but also transmembrane helices predicted by transmembrane hidden Markov model (TMHMM)
Server (25) (more than one helix or one helix located more than 40 amino acids away from the N terminus of the protein).
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two different proteins, endoplasmin (Fig. 5A) and plasminogen
activator inhibitor-1 (PAI-1) (Fig. 5B). The mass shift was
clearly seen in both cases (4 m/z), although the different
relative peak intensities for the non-labeled and labeled pep-
tides point to different incorporation rates of the label for
these two proteins. Fig. 5C shows the MS/MS spectra from
both the original and the labeled peptides from PAI-1 where
also a mass shift of 8 m/z was obvious.
Secreted proteins were classified into groups with similar
functions (Table I). For this, information was obtained from
Swiss-Prot and SOURCE (source.stanford.edu) databases.
The criteria for classification are not always uniform because
many proteins have more than one function that may place
them in more than one functional category. In this case, what
was considered as the main function of the protein was used
for classification in one of the five categories: signaling/regu-
latory, extracellular matrix, immune function, degradation, and
other.
In Supplemental Table A, non-secreted proteins (no signal
peptide predicted by SignalP according to SecretomeP) and
TABLE II
Secreted proteins (classical pathway; signal predicted by SignalP) that did not incorporate the label
The proteins were identified after SDS-PAGE fractionation and tryptic digest analysis by LC-MS/MS (99% confidence). EGF, epidermal
growth factor.
Accession no. Protein name
Identification based on only Arg-ending peptides
gi12643637 ADAMTS-4 (a disintegrin and metalloproteinase with thrombospondin motifs 4)
gi416746 Azurocidin (cationic antimicrobial protein CAP37) (heparin-binding protein)
gi23396490 Calsyntenin-1a
gi12643324 Cathepsin Z
gi116533 Clusterin (complement-associated protein SP-40,40) (complement cytolysis inhibitor)b
gi3023630 Cystatin Cb,c
gi462007 Dermatopontin (tyrosine-rich acidic matrix protein) (TRAMP)
gi37537873 EMILIN 1 (elastin microfibril interface-located protein 1)
gi134635 Extracellular superoxide dismutase (Cu-Zn) (EC-SOD)d
gi30581038 Fibulin-1
gi41017299 Latent transforming growth factor- -binding protein 2 (LTBP-2)
gi126279 Leukemia inhibitory factor (LIF) (differentiation-stimulating factor) (D factor)
gi119292 Leukocyte elastase (neutrophil elastase) (PMN elastase) (bone marrow serine protease)
gi20141203 Monocyte differentiation antigen CD14 (myeloid cell-specific leucine-rich glycoprotein)b
gi129825 Myeloperoxidase (MPO)
gi8928569 Nidogen-2 (NID-2) (osteonidogen)
gi50400889 Olfactomedin-like protein 1
gi1346908 Pentraxin-related protein PTX3 (pentaxin-related protein PTX3)
gi62900717 Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (lysyl hydroxylase 3) (LH3)
gi41017497 Prostaglandin-H2 D-isomerase (lipocalin-type prostaglandin-D synthase)
gi2501205 Protein-disulfide isomerase A6 (protein-disulfide isomerase P5)
gi129283 SPARC (osteonectin)b,c,d
gi52783469 Spondin-2 (mindin)
gi3334154 Stanniocalcin 1 (STC-1)
gi1351316 Tumor necrosis factor-inducible protein TSG-6 (TNF-stimulated gene 6 protein)
gi13432109 Vascular endothelial-cadherin (VE-cadherin) (cadherin-5) (7B4 antigen) (CD144 antigen)a
Identification based on Lys-ending peptides
gi57015285 Citrate synthase, mitochondrial precursor
gi3182940 Collagen  1(XII) chain
gi12643876 Fibulin-5 (FIBL-5) (developmental arteries and neural crest EGF-like protein)
gi6175096 Lactotransferrin (lactoferrin)
gi1708851 Laminin  -2 chain (S-laminin) (laminin B1s chain)
gi20141464 Lumican (keratan sulfate proteoglycan lumican) (KSPG lumican)
gi2501336 Membrane copper amine oxidase (vascular adhesion protein-1) (VAP-1)
gi129078 Mimecan (osteoglycin) (osteoinductive factor)
gi1171700 Neutrophil gelatinase-associated lipocalin (NGAL) (P25)c
gi51701718 Plexin B2 (MM1)
gi113576 Serum albuminb
gi9087217 Tenascin-X (TN-X)
a Signal peptide predicted by SignalP (24) but also transmembrane helices predicted by TMHMM Server (25) (more than one helix or one helix
located more than 40 amino acids away from the N terminus of the protein).
b Secreted proteins also identified in Ref. 19.
c Secreted proteins also identified in Ref. 17.
d Secreted proteins also identified in Ref. 18.
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non-classically secreted proteins (no signal peptide predicted
by SignalP but Neural Network score 0.6, marked as °) are
shown. In Supplemental Table B, classically secreted proteins
identified with confidence between 95 and 99% are shown.
DISCUSSION
Adipose tissue is recognized as an important organ for the
regulation of the whole-body energy metabolism through the
secretion of adipokines. Although major adipokines such as
leptin and adiponectin have been shown to be produced by
adipocytes, also other cell types that are part of the adipose
tissue produce adipokines or influence production of adipo-
kines by adipocytes. Fain et al. (28) showed that the majority
of adipokines measured in their study were released by non-
adipocyte cells in the tissue. This fact points out the relevance
of evaluating the adipose tissue secretome rather than the
adipocyte cell secretome. Here we describe the first proteom-
ics study on the adipose tissue secretome. A major issue in
characterizing the adipose tissue secretome is that protein
composition of the adipose tissue culture media is highly
dependent on the way the tissue culture is performed. This
not only has implications for proteomics studies but also for
other studies where adipose tissue culture is used to study
individual adipokines by ELISA because these peptide and
protein hormones are also present in serum and in the intra-
cellular protein fraction, which, as we demonstrate, are the
main sources of secretome contamination in adipose tissue
culture. Therefore, we established a tissue culture protocol
that minimizes contamination of the secretome with serum-
derived and intracellular proteins. After analyses of five differ-
ent culture setups we conclude that a tissue culture protocol
with one wash after the 1st h in culture and two or three
additional washes after overnight culture within a period of 8 h
followed by a 48–114-h incubation period (setups D and E,
Fig. 1) provides the optimal culture protocol to obtain a high
quality sample for secretome analyses. With this setup, total
protein concentration was reduced from17 g/ml to around
4 g/ml (setups D and E) at the end of the culture period (Fig.
2). This reduction is considerably higher than that observed
for setups A and B (from about 25 g/ml to about 18 g/ml).
Albumin and hemoglobin (serum contaminating proteins)
seemed to be highly reduced in setups D and E (Fig. 4.3), and
the dynamic range of the sample had decreased considerably
(Figs. 3 and 4.2) compared with setups A and B.
This new, improved culture protocol was used to charac-
terize the human adipose tissue secretome. Proteins were
identified, and the presence of a signal peptide was investi-
gated to distinguish those that are secreted in the medium
from those that are intracellular proteins, derived from dam-
aged cells. Furthermore a metabolic labeling approach was
FIG. 5. Examples of different incorporation ratios in labeled proteins. A, TOF MS spectra of endoplasmin peptide; B, TOF MS spectra
of PAI-1 peptide; C, MS/MS spectra of both original and labeled peptides in PAI-1.
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designed to differentiate between secreted proteins derived
from adipose tissue and serum proteins that still may be
present in low levels as a contaminant of the sample. Proteins
that contained a signal peptide and incorporated the label
were considered as genuinely secreted by adipose tissue and
not coming from an external source (serum or intracellular
origin). With this strategy, different incorporation rates of the
label into the proteins were noticed that can be related to
different turnover rates. In summary, a total of 297 proteins
were identified with 95% confidence. 259 proteins were
identified with 99%, among which were 108 secreted pro-
teins (Tables I and II). Of 108 secreted proteins, 70 proteins
incorporated the label (Table I), i.e. adiponectin, adipsin, gel-
solin, macrophage colony-stimulating factor-1 (MCSF), pig-
ment epithelium-derived factor, plasma retinol-binding pro-
tein, and PAI-1 among others. Interleukin-6 was also
detected, showing a clear incorporation of the label, although
it was identified with 95% confidence, (Supplemental Table
B). Adipocyte fatty acid-binding protein was identified as a
non-classically secreted protein (Supplemental Table A) with
label incorporation in agreement with a recent study by Xu et
al. (29) where they claimed that adipocyte fatty acid-binding
protein is a circulating biomarker released from adipocytes
into the bloodstream, closely associated with obesity and
metabolic syndrome. For 38 proteins containing a signal pep-
tide the label could not be detected (Table II). However, 26 of
these were identified with peptides ending on an arginine in
the C terminus (no lysine present), implying that it is still
possible that these proteins are secreted by adipose tissue
although label incorporation could not be confirmed (i.e. leuke-
mia inhibitory factor, pentraxin-related protein 3 (PTX3), and
secreted protein acidic and rich in cysteine (SPARC)). Finally the
label could not be detected in a group of 12 proteins even
though their peptides showed a lysine in the C terminus. This
fact may be due to a low incorporation rate or because the
protein was derived from serum, e.g. albumin is part of this latter
group (Table II).
In Supplemental Table A, non-secreted proteins (intracellu-
lar) or proteins predicted to be secreted via a non-classical
pathway are shown (151 proteins in total). Non-secreted pro-
teins, such as actin, histones, catalase, and proteasome sub-
units, are intracellular proteins that may be derived from dam-
aged cells in culture or from cleaved fragments of membrane
proteins. This together with the fact that albumin was still
detected indicates that, although with the improved tissue
culture setup sample quality had improved considerably, it was
not completely free of (high abundance) serum and intracellular
proteins. Nevertheless the dynamic range of the sample im-
proved considerably allowing a much more sensitive secretome
identification. The level of sensitivity that was reached with the
described procedure was in the low ng/ml range because adi-
ponectin, which was identified with99% confidence, reached
concentrations of around 10–20 ng/ml at the end of the culture
period as determined by ELISA in similar experiments.
Three studies have been published thus far on the adipo-
cyte cell secretome. We compared the results of those stud-
ies with our results on the human visceral adipose tissue
secretome. Chen et al. (19) identified 84 proteins secreted by
isolated rat adipocytes cells using 2D LC-MS/MS. Of these
proteins 29 were also identified in the present study (as indi-
cated in Tables I and II). Wang et al. (18) identified 27 proteins
that were secreted during mouse 3T3-L1 adipocyte cell dif-
ferentiation by two-dimensional gel electrophoresis-MS(/MS).
16 proteins were also identified in our study (as indicated in
Tables I and II). Of 20 secreted proteins identified by Kratch-
marova et al. (17) during differentiation of 3T3-L1 preadipo-
cytes by SDS-PAGE and LC-MS/MS, 13 were also found in
this study (as indicated in Tables I and II). Only five proteins
are shared between the three adipocyte cell studies and the
present study on adipose tissue. These proteins are adi-
ponectin, SPARC, gelsolin, adipsin, and matrix metallopro-
teinase-2. 68 proteins (classically secreted) identified in the
present study were not found in the other three studies. This
may be explained by the different starting materials (cells or
tissue), the different proteomics approaches that were fol-
lowed, and the different origins of the material (rat, mouse, or
human).
As mentioned before, although the adipocyte is the major
cell type in adipose tissue, this study shows that a substantial
number of proteins secreted by the tissue are released by
other cell types such as macrophages and endothelial cells. In
particular, some of the secreted proteins identified in the
present study were also identified in human macrophages by
a 2D gel approach (30). That is the case for endoplasmin,
gelsolin, protein-disulfide isomerase, protein-disulfide
isomerase A3, calreticulin, cathepsin D, and peroxiredoxin 4
among others. In the same way, PTX3 mRNA is expressed in
the stromal-vascular fraction of adipose tissue but not in fully
differentiated adipocytes; it plays a role in the regulation of
resistance to pathogens and inflammatory reactions, and the
PTX3 gene can be induced in adipocytes by TNF- (31).
Taking into account what has been reported previously (1, 7,
32–35) on proteins secreted by adipose tissue, we estimate
that in this study we identified 48 new proteins as being
secreted by adipose tissue.
The functional classification of the identified secreted pro-
teins, as shown in Table I, indicates that 39% of the proteins
are involved in the modulation of the extracellular matrix. An
example from this group is perlecan. It is a secreted proteo-
glycan, widely distributed as part of the basement membrane,
that may bind lipoprotein lipase and is localized close to the
cell surface so that it can participate in triacylglycerol hydrol-
ysis (36). Another example from this group is versican core
protein that plays a role in intercellular signaling and in con-
necting cells with the extracellular matrix. It may also take part
in the regulation of cell motility, growth, and differentiation
(37). The second largest group (27%) consists of proteins
involved in signaling and regulation. MCSF is part of this
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group. It promotes human adipose tissue hyperplasia, it is
up-regulated under conditions favoring adipose tissue growth
(obesity), and it is down-regulated by TNF- (38). Another
example is neuropilin-1, which is expressed by adipocytes
and is involved in regulation of angiogenesis (39). Proteins
classified as being involved in degradation (14%) are e.g.
cathepsins B and D. These are lysosomal proteases, but they
can also be secreted. The fact that a large portion of the
identified proteins are involved in the modulation of extracel-
lular matrix, protein degradation, and regulation of cellular
processes indicates that adipose tissue is a very actively
dividing tissue that is probably related to the demand to store
energy in the form of triglycerides. Therefore, the tissue has to
be flexible to increase or decrease storage capacity.
In conclusion, adipose tissue culture setup has a strong
influence on the quality of the sample and on detection of
secreted proteins. We show here that proteins secreted from
adipose tissue can be unequivocally identified by a qualitative
labeling approach that has the capability to distinguish the
source of relevant proteins. For the future it will be interesting
to compare adipose tissue secretomes from lean and obese
people to determine differences in protein expression that
may lead to the discovery of mechanisms involved in insulin
resistance and type 2 diabetes. For this, a quantitative label-
ing approach should be developed. We are currently working
on this topic.
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